Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Beta-Alanine Supplementation and Sport Climbing Performance.

  • 2021-05-18
  • International journal of environmental research and public health 18(10)
    • Krzysztof Sas-Nowosielski
    • Judyta Wyciślik
    • Piotr Kaczka

Study Design

Type
Randomized Controlled Trial (RCT)
Population
Fifteen elite climbers
Methods
Double-blind, pre/post experimental design, 4 weeks of 4.0 g·d^-1 BA or placebo, intermittent high-force high-velocity campus board exercise and two bouldering traverses
Blinding
Double-blind
Duration
four weeks
Funding
Unclear

Background

Supplementing β-alanine (BA) improves exercise performance in efforts that are highly dependent on anaerobic glycolysis. As it has not yet been established whether it relates to climbing, the current study aimed to investigate the effects of BA on climbing-specific performance.

Methods

Fifteen elite climbers performed intermittent high-force high-velocity campus board exercise, and two bouldering traverses, hard and easy. They ingested 4.0 g·d-1 BA or placebo for four weeks in a double-blind, pre/post experimental design.

Results

In the campus board trial, ANOVA revealed a tendency toward significance (p = 0.066). Post hoc analysis revealed that there was a significant (p = 0.002) and "large" (d = 1.55) increase in the total number of "slaps" in the BA group. No significant supplementation × group interaction was found in "hard" traverse and a significant interaction for mean changes in number of moves (p = 0.025) and in time to failure (p = 0.044) on an "easy" traverse. Post hoc analysis revealed that only the BA group significantly improved from baseline in number of moves (+9.5) and time to failure (+32 s). Effect sizes were d = 1.73 and d = 1.44, respectively.

Conclusions

Four weeks of BA supplementation can improve performance during continuous climbing lasting about 1 min and repeated bouts of upper body campus-like movements. However, it failed to enhance climbing of a shorter duration.

Research Insights

  • No significant supplementation × group interaction was found in 'hard' traverse

    Effect
    Neutral
    Effect size
    Small
    Dose
    4.0 g·d⁻¹
  • ANOVA revealed a tendency toward significance (p = 0.066)

    Effect
    Neutral
    Effect size
    Small
    Dose
    4.0 g·d⁻¹
  • a significant interaction for mean changes in number of moves (p = 0.025) ... Post hoc analysis revealed that only the BA group significantly improved from baseline in number of moves (+9.5) ... Effect sizes were d = 1.73

    Effect
    Beneficial
    Effect size
    Large
    Dose
    4.0 g/day
  • In the campus board trial, ANOVA revealed a tendency toward significance (p = 0.066).

    Effect
    Neutral
    Effect size
    Small
    Dose
    4.0 g/day
  • No significant supplementation × group interaction was found in 'hard' traverse

    Effect
    Neutral
    Effect size
    Small
    Dose
    4.0 g/day
  • and in time to failure (p = 0.044) on an 'easy' traverse. Post hoc analysis revealed that only the BA group significantly improved ... time to failure (+32 s). Effect sizes were ... d = 1.44

    Effect
    Beneficial
    Effect size
    Large
    Dose
    4.0 g/day
Back to top